Paper Details

  1. Home
  2. Paper Details

Risperidone: clinical safety and efficacy in schizophrenia.

Author: BorisonR L, DiamondB I, MeibachR C, PathirajaA P

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Risperidone, an antipsychotic medication, showed faster onset of antipsychotic activity than haloperidol. It was also associated with fewer extrapyramidal side effects and may even reduce the signs of tardive dyskinesia.
Paper Details　
Original Abstract of the Article :
Risperidone represents a unique pharmacology of potent antagonism of both serotonin and dopamine receptors. In a randomized, parallel-group, double-blind trial of risperidone vs. haloperidol and placebo in 36 schizophrenic patients in acute exacerbation, risperidone showed a quicker onset of antipsy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1381102

データ提供：米国国立医学図書館（NLM）

Risperidone: A New Oasis in the Desert of Schizophrenia Treatment

Schizophrenia is a complex and challenging mental illness, and finding effective treatments is a constant pursuit. This research explores the potential of risperidone, a unique antipsychotic with potent antagonism of both serotonin and dopamine receptors, in treating schizophrenia. The study meticulously compared the efficacy and side effect profile of risperidone to haloperidol and placebo in 36 patients experiencing acute exacerbation of schizophrenia. This investigation is akin to a desert explorer carefully comparing different paths to determine the most effective route.

Risperidone: A Potential Breakthrough in Schizophrenia Treatment

The study's findings suggest that risperidone may offer a superior side effect profile and potentially greater efficacy than haloperidol in treating schizophrenia. This is akin to discovering a more refreshing oasis in the desert, offering a more comfortable and effective solution. This research provides valuable insights into the potential benefits of risperidone for patients with schizophrenia.

Navigating the Desert of Schizophrenia: Finding Effective Treatments

This research highlights the importance of finding effective and well-tolerated treatments for schizophrenia. It's a reminder that the desert of this complex mental illness can be challenging to navigate, and that finding the right path requires careful consideration of individual needs and potential side effects. Just as a desert traveler seeks out the most reliable water sources, patients with schizophrenia should work closely with their psychiatrist to identify the most effective and safe treatment options.

Dr. Camel's Conclusion

This study offers a glimmer of hope in the vast desert of schizophrenia treatment. The potential benefits of risperidone are a testament to the ongoing quest for more effective and well-tolerated therapies for this challenging condition. As we continue to explore this complex landscape, we may uncover even more effective solutions, leading to better outcomes for those living with schizophrenia.

Date :
  1. Date Completed 1992-10-01
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

1381102

DOI: Digital Object Identifier

1381102

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.